Other languages Xtacy Therapeutics Corp. Deutsche Boerse AG

Equities

TT5

CA98423G1072

Market Closed - Deutsche Boerse AG Other stock markets 02:01:41 2024-05-16 EDT			5-day change	1st Jan Change
0.021 ^EUR	+2.44%		+90.91%	+68.00%

04-17	Xtacy Therapeutics Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	CI
04-15	Xtacy Therapeutics Corp. Reports Earnings Results for the Full Year Ended September 30, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xtacy Therapeutics Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	04-16
Xtacy Therapeutics Corp. Reports Earnings Results for the Full Year Ended September 30, 2023	04-15
Xtacy Therapeutics Corp. Expands MDMA Platform Pharmaceutical Grade Psychedelic Solutions to Solve Unmet Medical Needs	12-06
Global Wellness Strategies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-23
Global Wellness Strategies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-04-17
Global Wellness Strategies Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	23-04-03
Global Wellness Strategies Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	23-03-29
Global Wellness Strategies Inc. Auditor Raises 'Going Concern' Doubt	23-03-28
Global Wellness Strategies Inc. Announces Formation of Wholly Owned Pharma Subsidiary Focused on Clinical Trials	22-11-17
Global Wellness Strategies Effervescent Cannabis Products Approved to Launch GWS Achieves Major Milestone Partnering with Hempsana Holdings	22-10-31
Global Wellness Strategies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	22-09-02
Global Wellness Strategies Inc. Signs Custom Manufacturing Agreement with Hempsana Holdings	22-08-02
Global Wellness Strategies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	22-05-31
Global Wellness Strategies Inc. Announces Shanti Therapeutics Mdma Clinical Trial Update	22-05-12
Global Wellness Strategies Inc. Announces Appointment of Sud Agarwal as the Chief Medical Advisor	22-05-09
Global Wellness Strategies Inc. Announces Their Brand KaleidoMyco to Launch Their Proprietary Fizz Tablets	22-04-12
Global Wellness Strategies Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021	22-03-01
Global Wellness Strategies Inc. Announces the Addition of Two International Pedigreed Senior Advisors to Its Team and the Appointment of Meris Kott to the Board of Shanti Therapeutics	22-02-18
Global Wellness Strategies Inc. and iNGENü Sign Supply Agreement with PharmAla Biotech to Supply GMP MDMA	22-02-10
Global Wellness Strategies Inc. Reports Earnings Results for the Full Year Ended September 30, 2021	22-02-02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Xtacy Therapeutics Corp. Deutsche Boerse AG

Equities

TT5

CA98423G1072

Other languages

Filters